2026-10-25
ZoomInfo Technologies clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 26,630 −6.36%
S&P 7,354 −4.36%
GOLD $4,054 −1.44%
BTC $75,513 −6.08%
VIX 28.18 +69.66%
latest tape · as of 06:01 UTC
The Screen · Technology · Software - Application
ZoomInfo Technologies Inc.
GTM · Nasdaq · USD · Market cap $1.0B · 3,180 employees
ZoomInfo Technologies Inc., together with its subsidiaries, provides go-to-market intelligence and engagement platform for sales, marketing, operations, and recruiting professionals in the United States and internationally.
Not yet scored3.49 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 06:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price3.49 USD at the 5 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 5 Nov 2026
- Our regime readAccumulation, as of 5 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans to puts (put/call 3.65)
- Last reviewed5 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $5.00 to $6.97, base estimate $5.00 (screen dated 2026-11-05).
- Trend Accumulation
- Insiders insiders sold, $20,005, latest filing 2026-10-09
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 3.65, read 2026-11-05
- Ethical screen not yet scored
Price3.49 USD
Fair value5.00
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-10-18Read Accumulation4.08-14.6% to today Markup gives way to Accumulation after a 12% rise in 7 days
2026-10-11Read Markup3.65-4.5% to today Distribution gives way to Markup after a 6% slide in 9 days
2026-10-02Read Distribution3.90-10.6% to today ✓Markup gives way to Distribution after a 10% slide in 5 weeks
2026-08-31Read Markup4.31-19.1% to today Accumulation gives way to Markup after a 40% rise in 4 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its accumulation label.
ZoomInfo Technologies Inc. holds its Accumulation at $3.49. Consolidating, no directional conviction, held for 35 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 35 days |
| Price at the screen | $3.49 |
| Valuation | N/A trailing · 3.09 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 0.79 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 24.37% | Below 33% | Interest-bearing debt is just 24.4% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.06% | Below 33% | Cash held in interest-bearing accounts and securities is 0.1% of assets, under the one-third limit. | Pass |
| Receivables | 6.23% | Below 49% | Money owed to the company is 6.2% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
ZoomInfo Technologies clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
ZoomInfo Technologies clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 24%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 30% discount to our $5.00 fair value, 1.20% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 30.3% discount to the base estimate.
Third-party analyst targets: 18 covering, consensus Hold. The average target sits +15% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $5.00, with a range of $5.00 to $6.97, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it stands out
A 1%-growth business trading at just 3.1x forward earnings. That is a 30% discount to our $5.00 fair value: the market is pricing it cautiously while the fundamentals argue otherwise. 18 analysts rate it Hold with a $4.00 average target, about 15% above the screened price.
| Forward P/E | 3.1xexpensive even after accounting for its growth |
| EPS, trailing | -1.83 |
| EPS, forward | 1.13 |
| Revenue growth | +1.2%slow but positive growth |
| Profit margin | -43.0%currently unprofitable |
| Return on equity | -45.4%not currently earning a positive return on equity |
| FCF yield | 35.14% |
| Debt to equity | 1.83a meaningful debt load worth watching |
| Current ratio | 0.65below 1: short-term bills exceed liquid assets |
| Beta | 0.79steadier than the market |
| Short interest, float | 0.14% |
| 52-week range | 2.54 - 11.23 |
| Market cap | $1.0B |
| Employees | 3,180 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeGTM trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-04
Accumulation $4.24
-2.8% Entry 17
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 2.8% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 73%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it hold, with a mean price target of $5. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03
Accumulation $4.36
+0.0% Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 73%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it hold, with a mean price target of $5. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02
Accumulation $4.36
+0.0% Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 73%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it hold, with a mean price target of $5. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01
Accumulation $4.36
+0.2% Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.2% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 73%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it hold, with a mean price target of $5. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31
Accumulation $4.35
+0.0% Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 73%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it hold, with a mean price target of $5. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30
Accumulation $4.35
+0.0% Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 73%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it hold, with a mean price target of $5. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29
Accumulation $4.35
+0.9% Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.9% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 73%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it hold, with a mean price target of $5. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28
Accumulation $4.31
+0.0% Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 73%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it hold, with a mean price target of $5. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25
Accumulation $4.31
+5.6% Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 73%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it hold, with a mean price target of $5. Insiders have been net sellers over the past quarter.
2026-10-18
Accumulation · changed $4.08
+11.8% Entry 8
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 11.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 73%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it hold, with a mean price target of $5. Insiders have been net sellers over the past quarter.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- ZoomInfo launches New MCP Connector and API on Snowflake Yahoo Finance · 7d ago
- ZoomInfo (GTM) Stock Appears Fairly Priced On Insider Duty Claims Yahoo Finance · 7d ago
- 3 unpopular stocks that fall short Yahoo Finance · 8d ago
- 1 unprofitable stock for long-term investors and 2 we avoid Yahoo Finance · 10d ago
- 3 small-cap stocks walking a fine line Yahoo Finance · 13d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
RDVTRed Violet Inc
CXMSprinklr, Inc.
DFINDonnelley Financial Solutions, Inc.
WRDWeRide Inc.
LSPDLightspeed Commerce Inc.
UPBDUpbound Group, Inc.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-09 | O'Brien Michael Graham | CFO | S - Sale | 5,000 | $20,005 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $6.04 | -54.9% | · | $451 | -54.9% |
| 2 months | $5.23 | -47.9% | · | $521 | -47.9% |
| 3 months | $6.00 | -54.6% | · | $454 | -54.6% |
| 6 months | $9.96 | -72.6% | · | $274 | -72.6% |
| 1 year | $10.12 | -73.1% | · | $269 | -73.1% |
| 2 years | $12.50 | -78.2% | · | $218 | -78.2% |
| 3 years | $26.15 | -89.6% | · | $104 | -89.6% |
| 5 years | $46.44 | -94.1% | · | $59 | -94.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever GTM does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.